Early Anticoagulation for Recurrent Ischemic Stroke despite the Presence of Ventricular Bleeding

Abstract

Ischemic stroke due to atrial fibrillation (AF) is associated with a high risk of recurrence, which may occur early after the index event [1]. Oral anticoagulant therapy (OAT) is effective in preventing stroke recurrence and should be initiated as soon as possible [2]. However, the choice of the best timing to start OAT remains controversial and requires an accurate evaluation of the patient clinical conditions, to limit the risk of symptomatic hemorrhagic transformation (sHT).